Cero Therapeutics
South San Francisco
About Cero Therapeutics
CERo Therapeutics, Inc. is a new cellular immunotherapy company. We have created a hybrid platform that integrates innate and adaptive programs to eliminate disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $54.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Apr 2025)
- Ticker: nasdaq:CERO
- Website: cero.bio
Industries & Categories
Biotechnology, Life Science, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/cero-therapeutics-126426 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.